SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For Quarterly Period Ended June 30, 2002
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For Transition Period from to
------------ ------------
Commission File Number 1-12658
ALBEMARLE CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
VIRGINIA 54-1692118
- --------------------------- -------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
330 SOUTH FOURTH STREET
P. O. BOX 1335
RICHMOND, VIRGINIA 23210
- --------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code - (804) 788-6000
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
--- ---
Number of shares of common stock, $.01 par value, outstanding as of July 31,
2002: 41,676,088
1
ALBEMARLE CORPORATION
I N D E X
Page
Number(s)
--------
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
Consolidated Balance Sheets - June 30, 2002 and
December 31, 2001 3-4
Consolidated Statements of Income - Three- and Six-
Months Ended June 30, 2002 and 2001 5
Consolidated Statements of Comprehensive Income - Three-
and Six- Months Ended June 30, 2002 and 2001 6
Condensed Consolidated Statements of Cash Flows - Six Months
Ended June 30, 2002 and 2001 7
Notes to the Consolidated Financial Statements 8-15
ITEM 2. Management's Discussion and Analysis of Results
of Operations and Financial Condition and Additional
Information 16-24
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 25
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings 25
ITEM 5. Other Information 25
ITEM 6. Exhibits and Reports on Form 8-K 26
SIGNATURES 27
EXHIBIT INDEX 28
Exhibit 3(ii) By-Laws as Amended 29-51
Exhibit 99. List of Albemarle Corporation Officers 52
2
PART I - FINANCIAL INFORMATION
ITEM 1. Financial Statements
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars In Thousands)
June 30, December 31,
2002 2001
----------- ------------
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 33,404 $ 30,585
Accounts receivable, less allowance for doubtful
accounts (2002 - $2,778; 2001 - $4,193) 189,609 175,160
Inventories:
Finished goods 117,923 114,337
Raw materials 20,317 19,551
Stores, supplies and other 24,858 25,773
---------- ----------
163,098 159,661
Deferred income taxes and prepaid expenses 16,664 18,255
---------- ----------
Total current assets 402,775 383,661
---------- ----------
Property, plant and equipment, at cost 1,471,541 1,425,203
Less accumulated depreciation and amortization 940,185 895,531
---------- ----------
Net property, plant and equipment 531,356 529,672
Prepaid pension assets 134,526 128,195
Other assets and deferred charges 58,094 56,199
Goodwill 29,232 26,704
Other intangibles, net of amortization 5,983 5,044
---------- ----------
Total assets $1,161,966 $1,129,475
========== ==========
See accompanying notes to the consolidated financial statements.
3
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars In Thousands)
June 30, December 31,
2002 2001
----------- ------------
(Unaudited)
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 70,545 $ 63,559
Long-term debt, current portion 198,838 157,862
Accrued expenses 62,326 59,978
Dividends payable 5,418 5,915
Income taxes payable 24,458 16,523
---------- ----------
Total current liabilities 361,585 303,837
---------- ----------
Long-term debt 12,072 12,353
Other noncurrent liabilities 131,825 120,269
Deferred income taxes 115,097 99,714
Shareholders' equity:
Common stock, $.01 par value, issued and
outstanding- 41,675,338 in 2002
and 45,498,201 in 2001 417 455
Additional paid-in capital 2,119 51,025
Accumulated other comprehensive loss (7,120) (18,453)
Retained earnings 545,971 560,275
---------- ----------
Total shareholders' equity 541,387 593,302
---------- ----------
Total liabilities and shareholders' equity $1,161,966 $1,129,475
========== ==========
See accompanying notes to the consolidated financial statements.
4
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands Except Per-Share Amounts)
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
------------------- -------------------
2002 2001 2002 2001
-------- -------- -------- --------
Net sales $245,051 $211,286 $469,679 $435,696
Cost of goods sold 186,896 162,550 355,764 327,505
-------- -------- -------- --------
Gross profit 58,155 48,736 113,915 108,191
Selling, general and administrative
expenses 28,916 22,186 54,620 44,890
Research and development
expenses 4,020 5,433 8,796 11,210
Special item -- -- 850 --
-------- -------- -------- --------
Operating profit 25,219 21,117 49,649 52,091
Interest and financing expenses (1,235) (1,086) (2,460) (2,155)
Other income, net 2,276 1,236 3,068 2,818
-------- -------- -------- --------
Income before income taxes 26,260 21,267 50,257 52,754
Income taxes 5,566 6,462 12,765 15,404
-------- -------- -------- --------
Net income $ 20,694 $ 14,805 $ 37,492 $ 37,350
======== ======== ======== ========
Basic earnings per share $ 0.50 $ 0.32 $ 0.88 $ 0.81
======== ======== ======== ========
Diluted earnings per share $ 0.48 $ 0.32 $ 0.86 $ 0.80
======== ======== ======== ========
Cash dividends declared per
share of common stock $ 0.13 $ -- $ 0.26 $ 0.26
======== ======== ======== ========
See accompanying notes to the consolidated financial statements.
5
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars In Thousands)
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
------------------ -----------------
2002 2001 2002 2001
------- ------- ------- -------
Net income $20,694 $14,805 $37,492 $37,350
Other comprehensive income (loss),
net of tax:
Unrealized (loss) gain on securities
available for sale (123) 32 (96) (239)
Foreign currency translation
adjustments 12,380 (2,700) 11,429 (6,501)
------- ------- ------- -------
Other comprehensive income (loss) 12,257 (2,668) 11,333 (6,740)
------- ------- ------- -------
Comprehensive income $32,951 $12,137 $48,825 $30,610
======= ======= ======= =======
See accompanying notes to the consolidated financial statements.
6
ALBEMARLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars In Thousands)
(Unaudited)
Six Months Ended
June 30,
-------------------
2002 2001
-------- --------
Cash and cash equivalents at beginning of year $ 30,585 $ 19,300
-------- --------
Cash flows from operating activities:
Net income 37,492 37,350
Adjustments to reconcile net income to cash flows from
operating activities:
Depreciation and amortization 40,475 37,014
Working capital decrease excluding cash
and cash equivalents 7,959 743
Other, net (7,610) (6,696)
-------- --------
Net cash provided from operating activities 78,316 68,411
-------- --------
Cash flows from investing activities:
Capital expenditures (19,267) (28,558)
Investments in joint ventures and nonmarketable securities (3,164) (6,193)
Acquisition of business -- (45,375)
Restricted cash from industrial revenue bond proceeds 1,741 --
Other, net 2,412 676
-------- --------
Net cash used in investing activities (18,278) (79,450)
-------- --------
Cash flows from financing activities:
Proceeds from borrowings 103,995 44,000
Purchases of common stock (92,943) --
Repayments of long-term debt (64,969) (31,014)
Dividends paid (11,316) (12,239)
Proceeds from exercise of stock options 2,156 598
-------- --------
Net cash (used in) provided from financing activities (63,077) 1,345
-------- --------
Net effect of foreign exchange on cash and cash equivalents 5,858 (1,719)
-------- --------
Net increase (decrease) in cash and cash equivalents 2,819 (11,413)
-------- --------
Cash and cash equivalents at end of period $ 33,404 $ 7,887
======== ========
See accompanying notes to the consolidated financial statements
7
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
1. In the opinion of management, the accompanying consolidated financial
statements of Albemarle Corporation and Subsidiaries ("Albemarle" or "the
Company") contain all adjustments necessary for a fair presentation, in all
material respects, of the Company's consolidated financial position as of
June 30, 2002, and December 31, 2001, the consolidated results of
operations and comprehensive income for the three- and six-month periods
ended June 30, 2002, and 2001, and condensed consolidated cash flows for
the six month periods ended June 30, 2002, and 2001. All adjustments are of
a normal and recurring nature. These consolidated financial statements
should be read in conjunction with the consolidated financial statements
and notes thereto included in the Company's 2001 Annual Report & Form
10-K/A as amended on May 31, 2002. The December 31, 2001 consolidated
balance sheet data was derived from audited financial statements, but does
not include all disclosures required by generally accepted accounting
principles. The results of operations for the three- and six-month periods
ended June 30, 2002, are not necessarily indicative of the results to be
expected for the full year. Certain revisions have been made to three- and
six-months pro forma amounts ended June 30, 2001 to reflect final purchase
price allocations of the Martinswerk GmbH and the custom and fine chemicals
business of ChemFirst Inc. acquisitions.
2. Long-term debt consists of the following:
June 30, December 31,
2002 2001
-------- ------------
Variable-rate bank loans $193,510 $144,600
Foreign borrowings 5,403 13,584
Industrial revenue bonds 11,000 11,000
Miscellaneous 997 1,031
-------- --------
Total 210,910 170,215
Less amounts due within one year 198,838 157,862
-------- --------
Long-term debt $ 12,072 $ 12,353
======== ========
The Company's Competitive Advance and Revolving Facility Agreement
("Revolving Credit Agreement") will mature on September 29, 2002.
Accordingly, the balance outstanding thereunder is included in current
liabilities. The Company anticipates entering into a new three-year
long-term credit agreement by September 1, 2002.
3. Cost of goods sold includes foreign exchange transaction gains (losses) of
$283 and ($85) and $1,074 and ($587) for the three- and six-months ended
June 30, 2002 and 2001, respectively.
8
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
4. Basic and diluted earnings per share for the three- and six-month periods
ended June 30, 2002 and 2001, are calculated as follows:
Three Months Ended Six Months Ended
June 30, June 30,
------------------ -----------------
2002 2001 2002 2001
------- ------- ------- -------
Basic earnings per share
Numerator:
Income available to shareholders,
as reported $20,694 $14,805 $37,492 $37,350
------- ------- ------- -------
Denominator:
Average number of shares of
common stock outstanding 41,618 45,873 42,528 45,855
------- ------- ------- -------
Basic earnings per share $ 0.50 $ 0.32 $ 0.88 $ 0.81
======= ======= ======= =======
Diluted earnings per share
Numerator:
Income available to shareholders,
as reported $20,694 $14,805 $37,492 $37,350
------- ------- ------- -------
Denominator:
Average number of shares of
common stock outstanding 41,618 45,873 42,528 45,855
Shares issuable upon
exercise of stock options 1,204 794 978 821
------- ------- ------- -------
Total shares 42,822 46,667 43,506 46,676
------- ------- ------- -------
Diluted earnings per share $ 0.48 $ 0.32 $ 0.86 $ 0.80
======= ======= ======= =======
5. Cash dividends declared for the six-month period ended June 30, 2001
totaled $0.26 per share which included a dividend of $0.13 per share
declared on February 28, 2001, payable April 1, 2001, as well as a dividend
of $0.13 per share declared March 28, 2001, payable July 1, 2001.
9
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
6. The significant differences between the U.S. Federal statutory income tax
rate on pretax income and the effective income tax rate for the three- and
six-month periods ended June 30, 2002 and 2001, respectively, are as
follows:
% of Income Before Income Taxes
-------------------------------------
Three Months Ended Six Months Ended
June 30, June 30,
------------------ ----------------
2002 2001 2002 2001
---- ---- ---- ----
Federal statutory rate 35.0% 35.0% 35.0% 35.0%
Foreign sales corporation benefit (2.4) (2.5) (2.4) (2.5)
State taxes, net of federal tax benefit 1.0 1.0 1.0 1.0
Depletion (1.7) (2.2) (1.8) (1.7)
Reversal of valuation allowance -- -- -- (2.0)
Other, net (1.2) (0.9) (1.4) (0.6)
---- ---- ---- ----
Effective income tax rate on operations 30.7 30.4 30.4 29.2
Federal income tax settlement (9.5) -- (5.0) --
---- ---- ---- ----
Effective income tax rate 21.2% 30.4% 25.4% 29.2%
==== ==== ==== ====
On April 25, 2002, following approval by the congressional Joint Committee
on Taxation, the Company received a settlement of $3,777, including
interest of $1,285 after income taxes, from the Internal Revenue Service on
its claims for adjustment of export benefits for the years 1994 and 1995.
Consequently, the effective tax rate for the second quarter and first six
months of 2002 was 21.2% and 25.4%, respectively. The Company expects to
maintain its targeted income tax rate of 30% for the last half of 2002 and
a blended rate for the year of approximately 28%.
During the first quarter of 2001, the Company released a valuation
allowance that had been required on a deferred tax asset related to the
Company's facilities in Louvain-la-Neuve, Belgium, which was established in
1996 when the Company's Olefins Business was sold.
7. On May 31, 2001, the Company acquired Martinswerk GmbH and certain U.S.
working capital for approximately $34,000 in cash plus expenses and the
assumption of approximately $63,000 in current and long-term liabilities.
The assets acquired included Martinswerk's manufacturing facilities and
headquarters in Bergheim, Germany and its 50-percent stake in Magnifin
Magnesiaprodukte GmbH, which has manufacturing facilities at St. Jakobs
Breitenau, Austria. The acquisition was financed through the Company's
existing Revolving Credit Agreement. The acquisition was accounted for by
the purchase method of accounting, and accordingly, the operating results
have been included in the Company's consolidated results of operations from
the date of acquisition.
10
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
See pro forma financial information presented below. The purchase price
allocation was finalized during the quarter ended June 30, 2002.
Martinswerk produces mineral-based flame retardants for the plastics and
rubber markets, brightening pigments for high-quality paper applications
and specialty aluminum oxides for polishing, catalyst and niche ceramic
applications. Magnifin produces high-purity magnesium hydroxide flame
retardant products used in applications requiring higher processing
temperatures.
On July 1, 2001, the Company acquired the custom and fine chemicals
businesses of ChemFirst Inc. for approximately $79,000 in cash, plus the
assumption of certain current liabilities and expenses associated with the
acquisition. The acquisition was financed through the Company's existing
Revolving Credit Agreement. The Asset Purchase Agreement provided for
additional contingent payments to ChemFirst Inc. which are dependant upon
the contribution margin of certain products and are not expected to exceed
$10,000. Additional payments, if any, will be recorded as goodwill. The
acquisition was accounted for by the purchase method of accounting, and
accordingly, the operating results have been included in the Company's
consolidated results of operations from the date of acquisition. See pro
forma financial information presented below. The assets acquired included
working capital, property, plant and equipment and certain intangibles,
including goodwill and technical know how. The purchase price allocation
was finalized during the quarter ended June 30, 2002. The new businesses
acquired focus on the manufacture of custom and proprietary fine chemicals
and chemical services for the pharmaceutical and life sciences industries.
They also included additives for ultraviolet light-cured polymer coatings,
which should broaden the portfolio of Albemarle's polymer chemicals
business. Included is a multi-functional manufacturing plant in Tyrone,
Pennsylvania, and a cGMP (current Good Manufacturing Practices) pilot plant
in Dayton, Ohio.
Pro forma information is presented as follows for the three- and six-month
periods ended June 30, 2001, as if Martinswerk GmbH and Martinswerk's
50-percent stake in Magnifin Magnesiaprodukte GmbH, and the custom and fine
chemicals businesses of ChemFirst Inc. had been acquired on January 1,
2001.
Three Months Ended Six Months Ended
June 30, 2001 June 30, 2001
------------------ ----------------
Net sales $240,604 $506,195
Net income $ 14,782 $ 39,353
Basic earnings per share $ 0.32 $ 0.86
Diluted earnings per share $ 0.32 $ 0.84
11
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
The pro forma information presented above primarily includes adjustments
for interest expense, depreciation expense and amortization of intangibles.
8. On February 13, 2002, the Company completed the purchase of 4,000,000
shares of its common stock from Bruce C. Gottwald and his related immediate
family interests for an aggregate price of $92,680. The Company's purchase
price was 25 cents per share less than the weighted average trading price
from New York Stock Exchange transactions in Albemarle common stock during
the 10 business days' period beginning with the third business day
following the announcement of Albemarle's 2001 year-end earnings.
9. During the first quarter of 2002, the Company continued its efforts to
reduce operating costs through an involuntary separation program that
resulted in a special charge of $850 ($541 after income taxes or 1 cent per
share on a diluted basis). The program impacted a total of 12 salaried
employees throughout the Company. The following table summarizes the total
special charges assumed related to the involuntary separation program:
Six-Months Ended
June 30, 2002
----------------
Total 2002 workforce reduction charge $1,114
Less: over accrual from prior year accruals 264
------
Net workforce reductions charged for 2002 $ 850
======
Approximately $900 of the total 2002 workforce accrual charge was paid
during the period ended June 30, 2002. In addition, essentially all of the
fourth quarter 2001 work force accrual was paid during the first quarter of
2002.
10. During the six months ended June 30, 2002, the Company recorded a net
charge of $2,300 ($1,465 after income taxes or 3 cents per share on a
diluted basis) to cost of sales that related to the discontinuance of
product support for and the withdrawal from a water treatment venture. The
Company's balance sheet at June 30, 2002, included entries reflecting the
accrual of a probable insurance recovery of $4,000 in other assets and
accruals totaling $2,900 in current and noncurrent liabilities, net of
payments made to date.
12
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
11. The Company has recorded environmental liabilities of $32,735 and $30,245
at June 30, 2002 and December 31, 2001, respectively, which represents
management's best estimate of the Company's future remediation and other
anticipated environmental costs relating to past operations. The Company
believes that such estimate is reasonable based on available information
and that the liabilities and related loss contingencies and the expected
outcome of uncertainties have been adequately described in the Company's
consolidated financial statements at December 31, 2001. Although it is
difficult to quantify the potential financial impact of compliance with
environmental protection laws, management estimates, based on the latest
available information, that there is a reasonable possibility that future
environmental remediation costs associated with the Company's past
operations, in excess of amounts already recorded, could be up to
approximately $10,000 before income taxes, to be incurred over a period of
time. However, the Company believes that any sum it may be required to pay
in connection with environmental remediation matters in excess of the
amounts recorded should occur over a period of time and should not have a
material adverse impact on its financial condition or results of
operations, but could have a material adverse impact in a particular
quarterly reporting period.
12. The Company is a global manufacturer of specialty polymer and fine
chemicals, currently grouped into two operating segments: Polymer Chemicals
and Fine Chemicals. The operating segments were determined based on
management responsibility. The Polymer Chemicals segment is comprised of
flame retardants, organometallics and catalysts, and polymer additives and
intermediates. The Fine Chemicals operating segment is comprised of
agrichemicals and pharmachemicals, performance chemicals and fine chemistry
services. Segment data includes intersegment transfers of raw materials at
cost and foreign exchange gains and losses as well as allocations for
certain corporate costs. The corporate and other expenses include certain
corporate-related items not allocated to the reportable segments.
13
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
Three Months Ended June 30,
---------------------------------------
2002 2001
------------------ ------------------
Summary of segment results Revenues Income Revenues Income
- -------------------------- -------- ------- -------- -------
Polymer Chemicals $136,104 $19,028 $108,916 $15,288
Fine Chemicals 108,947 12,189 102,370 9,198
-------- ------- -------- -------
Segment totals $245,051 31,217 $211,286 24,486
======== ========
Corporate and other expenses (5,998) (3,369)
------- -------
Operating profit 25,219 21,117
Interest and financing expenses (1,235) (1,086)
Other income, net 2,276 1,236
------- -------
Income before income taxes $26,260 $21,267
======= =======
Six Months Ended June 30,
---------------------------------------
2002 2001
------------------ ------------------
Summary of segment results Revenues Income Revenues Income
- -------------------------- -------- ------- -------- -------
Polymer Chemicals $252,567 $30,757 $229,872 $36,146
Fine Chemicals 217,112 28,692 205,824 24,090
-------- ------- -------- -------
Segment totals $469,679 59,449 $435,696 60,236
======== ========
Corporate and other expenses (9,800) (8,145)
------- -------
Operating profit 49,649 52,091
Interest and financing expenses (2,460) (2,155)
Other income, net 3,068 2,818
------- -------
Income before income taxes $50,257 $52,754
======= =======
13. During July 2001, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standard ("SFAS") No. 142, "Goodwill and
Other Intangible Assets." SFAS No. 142 eliminates the amortization of
goodwill and instead requires a periodic review of any goodwill balance for
possible impairment. SFAS No. 142 also requires that goodwill be allocated
at the reporting unit level. This statement was effective for years
beginning after December 15, 2001, with the exception of goodwill and
intangible assets acquired after June 30, 2001, which were subject
immediately to the nonamortization and amortization provisions of the
statement. For financial reporting purposes, the Company discontinued
amortization of goodwill as of January 1, 2002, with the exception of
goodwill associated with the July 2001 acquisition of the custom and fine
chemicals businesses of ChemFirst Inc., for which amortization, in
accordance with SFAS No. 142, never began, and is in compliance with
periodic impairment test procedures. The Company has completed its
14
ALBEMARLE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In Thousands Except Share and Per-Share Amounts)
(Unaudited)
transitional goodwill impairment testing and has determined that goodwill
is not impaired at January 1, 2002. The following schedule presents net
income, basic earnings per share and diluted earnings per share, exclusive
of goodwill amortization expense, including any related tax effects, for
all periods presented in which the standard had not been adopted.
Three Months Six Months
Ended Ended
June 30, 2001 June 30, 2001
------------- -------------
Reported net income $14,805 $37,350
Add back: goodwill amortization, net of tax 257 539
------- -------
Adjusted net income $15,062 $37,889
======= =======
Basic earnings per share:
Reported net income $ 0.32 $ 0.81
Goodwill amortization, net of tax 0.01 0.01
------- -------
Adjusted net income $ 0.33 $ 0.82
======= =======
Diluted earnings per share:
Reported net income $ 0.32 $ 0.80
Goodwill amortization, net of tax 0.01 0.01
------- -------
Adjusted net income $ 0.33 $ 0.81
======= =======
During October 2001, the FASB issued SFAS No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets," which addresses financial
accounting and reporting for the impairment or disposal of long-lived
assets. The Company adopted SFAS No. 144 on January 1, 2002. This Statement
has not had an impact on the Company's financial statements as of June 30,
2002.
During April 2002, the FASB issued SFAS No. 145, "Rescission of FASB
Statements Number 4, 44, and 64, Amendment of FASB Statement Number 13, and
Technical Corrections." The provisions of this statement are generally
effective for fiscal years beginning after May 15, 2002 and are not
expected to have a material impact on the Company's future financial
statements.
On July 30, 2002, the FASB issued SFAS No. 146, "Accounting for Costs
Associated with Exit or Disposal Activities," which addresses financial
accounting and reporting for costs associated with exit or disposal
activities and nullifies Emerging Issues Task Force (EITF) Issue No. 94-3,
"Liability Recognition for Certain Employee Termination Benefits and Other
Costs to Exit an Activity." This Statement is effective for exit or
disposal activities initiated after December 31, 2002 and is not expected
to have a material impact on the Company's future financial statements.
15
ITEM 2. Management's Discussion and Analysis of Results of Operations and
Financial Condition and Additional Information
The following is management's discussion and analysis of certain
significant factors affecting the results of operations of Albemarle
Corporation ("Albemarle" or "the Company") during the periods included in
the accompanying consolidated statements of income and changes in the
Company's financial condition since December 31, 2001.
Some of the information presented in the following discussion may
constitute forward-looking comments within the meaning of the Private
Securities Litigation Reform Act of 1995. Although the Company believes its
expectations are based on reasonable assumptions within the bounds of its
knowledge of its business and operations, there can be no assurance that
actual results will not differ materially from its expectations. Factors
that could cause actual results to differ from expectations include,
without limitation, the timing of orders received from customers, the gain
or loss of significant customers, competition from other manufacturers,
changes in the demand for the Company's products, increases in the cost of
the products, changes in the market in general, fluctuations in foreign
currencies and significant changes in new product introduction resulting in
an increase in capital project requests and approvals leading to additional
capital spending.
Results of Operations
Second Quarter 2002 Compared with Second Quarter 2001
Net sales for second quarter 2002 of $245.1 million were up $33.8 million,
or 16.0% from second quarter 2001 net sales of $211.3 million, primarily
due to $25.7 million in second quarter 2002 net sales from the acquisitions
of Martinswerk GmbH and the custom and fine chemicals businesses of
ChemFirst Inc., which were completed on May 31, 2001 and July 1, 2001,
respectively. The increase in net sales also reflected higher shipments
offset by lower pricing in flame retardants ($14.8 million) partially
offset by lower shipments and selling prices in performance chemicals ($6.2
million).
The gross profit margin increased to 23.7% in second quarter 2002 from
23.1% for the corresponding period in 2001. Second quarter 2002 operating
profit was up 19.4% or $4.1 million from second quarter 2001 operating
profit primarily due to higher shipments, offset, in part, by lower selling
prices in flame retardants, favorable raw material and manufacturing fixed
costs and the favorable net effects of the mid-year 2001 acquisitions.
Selling, general and administrative expenses ("SG&A") and research and
development expenses ("R&D"), increased 19.3% or $5.3 million in the second
quarter of 2002 versus second quarter 2001 primarily due to costs related
to the businesses acquired in 2001 ($3.2 million) as well as higher
employee incentive costs in the current period versus the corresponding
2001 period. As a percentage of net sales, selling, general and
administrative expenses, and research and development expenses, were 13.4%
in 2002 versus 13.1% in the 2001 quarter.
16
Operating Segments
Net sales by reportable business operating segment for the second quarter
periods ended June 30, 2002 and 2001 are as follows:
Net Sales
(In Thousands)
-------------------
2002 2001
-------- --------
Polymer Chemicals $136,104 $108,916
Fine Chemicals 108,947 102,370
-------- --------
Segment totals $245,051 $211,286
======== ========
Polymer Chemicals' net sales for second quarter 2002 increased 25.0%, or
$27.2 million, from second quarter 2001 net sales, primarily due to $11.1
million in net sales from the May 31, 2001 acquisition of Martinswerk GmbH,
higher shipments partly offset by lower prices in flame retardants ($14.8
million) and favorable pricing in catalysts and additives ($1.3 million).
Fine Chemicals' net sales for second quarter 2002 increased 6.4% or $6.6
million from second quarter 2001 primarily due to net sales of $14.6
million from the mid-year 2001 acquisitions of Martinswerk GmbH and the
custom and fine chemicals businesses of ChemFirst Inc., offset, in part, by
lower shipments and selling prices in performance chemicals ($6.2 million)
and lower shipments in pharmachemicals and agrichemicals ($1.9 million).
Operating profit by reportable business operating segment for the second
quarter periods ended June 30, 2002, and 2001 are as follows:
Operating Profit
(In Thousands)
-----------------
2002 2001
------- -------
Polymer Chemicals $19,028 $15,288
Fine Chemicals 12,189 9,198
------- -------
Segment totals 31,217 24,486
Corporate and other expenses (5,998) (3,369)
------- -------
Operating profit $25,219 $21,117
======= =======
Polymer Chemicals' second quarter 2002 segment operating profit was up
24.5% or $3.7 million from second quarter 2001 primarily due to higher
sales volumes ($8.9 million), favorable raw material costs ($3.6 million),
offset, in part, by lower selling prices ($4.0 million) and higher
manufacturing costs ($3.7 million) and higher SG&A and R&D on new
acquisitions ($1.1 million).
Fine Chemicals' second quarter 2002 segment operating profit increased
32.5% or $3.0 million from second quarter 2001 primarily due to favorable
plant utilization and production costs ($7.3 million) and favorable raw
material costs ($5.8 million) offset, in part, by lower volumes ($5.8
million) and sales prices ($3.0 million) and higher SG&A and R&D on new
acquisitions ($1.0 million).
17
Corporate and other expenses for the second quarter of 2002 were up 78.0%,
or $2.6 million from second quarter 2001, primarily due to higher employee
incentive award costs in the 2002 period.
Interest and Financing Expenses
Interest and financing expenses for second quarter 2002 increased $0.1
million from $1.1 million in second quarter 2001.
Other Income, Net
Other income, net for the second quarter 2002 amounted to $2.3 million, up
$1.1 million from the corresponding period in 2001. Second quarter 2002
includes interest income of $2.0 million from the Federal Internal Revenue
Service ("IRS") income tax settlement received in April 2002, mentioned
below.
Income Taxes
Income taxes for second quarter 2002 were lower compared to the same period
in 2001 primarily due to an IRS income tax settlement, received in April
2002, in the amount of $2.5 million which related to an adjustment of
export benefits for the years 1994 and 1995. Consequently, the second
quarter 2002 effective income tax rate was 21.2%, down from 30.4% in second
quarter 2001. Excluding the income tax settlement, the second quarter 2002
effective income tax rate was 30.7%. The Company expects to maintain its
targeted income tax rate of 30% for the last half of 2002 and a blended
rate for the year of approximately 28%.
Results of Operations
Six Months 2002 Compared with Six Months 2001
Net sales for the first six months of 2002 amounted to $469.7 million, up
7.8% or $34.0 million from net sales of $435.7 million for the
corresponding period of 2001 primarily due to $61.3 million in net sales in
the 2002 period from the mid-year 2001 acquisitions of Martinswerk GmbH and
the custom and fine chemicals businesses of ChemFirst Inc. The increase in
net sales was partially offset by product mix in performance chemicals
($12.9 million), lower shipments of agrichemicals and pharmachemicals ($8.6
million) and catalysts and additives ($6.6 million).
The gross profit margin was 24.3% in the first six months of 2002 which was
relatively constant with the 24.8% margin for the corresponding period in
2001. The first six months of 2002 operating profit was down 4.7% or $2.4
million from the 2001 period. The first six months of 2002 includes a
charge of $2.3 million ($6.3 million, net of a probable insurance recovery
of $4.0 million) to cost of sales related to the discontinuance of product
support for and the withdrawal from a water treatment venture as well as a
$0.9 million charge for workforce reductions as the Company continues to
aggressively pursue its cost reduction efforts. Favorable plant utilization
and production costs in performance chemicals, agrichemcials and
pharmachemicals and favorable raw material costs offset lower selling
prices in flame retardants and lower shipments in catalysts and additives
for the six months of 2002 versus the corresponding 2001 period.
18
Selling, general and administrative expenses and research and development
expenses increased 13.0% or $7.3 million in the first six months of 2002
versus the 2001 period primarily due to costs related to the businesses
acquired in 2001 of $5.3 million as well as higher employee incentive costs
in the current period. As a percentage of net sales, selling, general and
administrative expenses, including research and development expenses, were
13.5% in the first six months 2002 versus 12.9% in the corresponding period
of 2001.
Operating Segments
Net sales by reportable business operating segment for the six-months
periods ended June 30, 2002 and 2001 are as follows:
Net Sales
-------------------
2002 2001
-------- --------
Polymer Chemicals $252,567 $229,872
Fine Chemicals 217,112 205,824
-------- --------
Segment totals $469,679 $435,696
======== ========
Polymer Chemicals' net sales for the first six months of 2002 increased
9.9% or $22.7 million from the corresponding period in 2001 primarily due
to the increase in net sales of $28.3 million, resulting from the May 31,
2001, acquisition of Martinswerk GmbH offset, in part, by lower shipments
in catalysts and additives of $6.6 million.
Fine Chemicals' net sales for the first six months of 2002 increased 5.5%
or $11.3 million from the corresponding period in 2001 primarily due to the
increase in net sales of $33.0 million resulting from the mid-year 2001
acquisitions of Martinswerk GmbH and the custom and fine chemicals
businesses of ChemFirst Inc. offset, in part, by product mix in performance
chemicals of $12.9 million and lower shipments in pharmachemicals and
agrichemicals of $8.6 million.
Operating profit by reportable business operating segment for the
six-months periods ended June 30, 2002, and 2001 are as follows:
Operating Profit
-----------------
2002 2001
------- -------
Polymer Chemicals $30,757 $36,146
Fine Chemicals 28,692 24,090
------- -------
Segment totals 59,449 60,236
Corporate and other expenses (9,800) (8,145)
------- -------
Operating profit $49,649 $52,091
======= =======
Polymer Chemicals' first six months of 2002 segment operating profit was
down 14.9% or $5.4 million from the corresponding period in 2001 primarily
due to lower selling prices ($8.3 million), higher manufacturing costs
($3.5 million), higher SG&A and R&D on new acquisitions ($2.8 million), the
unfavorable net effects of foreign exchange ($1.2 million), a first quarter
2002 reclassification of bad debt expense to the Polymer Chemicals' segment
from corporate and other expenses ($2.0 million), offset, in part, by
favorable raw material costs ($8.2 million) and higher shipments ($4.2
million).
19
Fine Chemicals' first six months of 2002 segment operating profit increased
19.1% or $4.6 million from the corresponding period in 2001 primarily due
to favorable plant utilization and production costs ($15.7 million) and
favorable raw material costs ($10.7 million), offset, in part, by lower
shipments ($8.7 million) and sales prices ($7.6 million) and a charge of
$2.0 million ($6.3 million, net of a probable insurance recovery of $4.0
million) that related to the discontinuance of product support for and the
withdrawal from a water treatment venture, higher SG&A and R&D on new
acquisitions ($2.5 million) and the unfavorable net effects of foreign
exchange ($0.4 million).
Corporate and other expenses for the first six months of 2002 were up
20.3%, or $1.7 million, from the corresponding period in 2001 primarily due
to higher employee incentive award costs and a first quarter 2002 workforce
reduction charge of $0.9 million, offset, in part, by a first quarter 2002
reclassification of bad debt expense to the Polymer Chemicals segment
operating profit from corporate and other expenses ($2.0 million).
Interest and Financing Expenses
Interest and financing expenses for the first six months of 2002 increased
$0.3 million from $2.2 million in the corresponding period of 2001
primarily due to higher average outstanding debt, partially offset by a
lower interest rate in the 2002 period.
Other Income, Net
Other income, net for the first six months of 2002 amounted to $3.1
million, up $0.3 million from the corresponding period in 2001.
Income Taxes
Income taxes for the first six months of 2002 were lower compared to the
same period in 2001 due to an IRS income tax settlement received in April
2002 which amounted to $2.5 million that related to an adjustment of export
benefits for the years 1994 and 1995 and lower income before taxes in the
2002 period, partially offset by the reversal in 2001 of a deferred tax
valuation allowance associated with one of the Company's foreign
subsidiaries. The effective income tax rate for the first six months of
2002 was 25.4%, down from 29.2% in the corresponding period of 2001.
Excluding the income tax settlement, the first six months of 2002 effective
income tax rate was 30.4%. The Company expects to maintain its targeted
income tax rate of 30% for the last half of 2002 and a blended rate for the
year of approximately 28%.
Financial Condition and Liquidity
Cash and cash equivalents at June 30, 2002, were $33.4 million,
representing an increase of $2.8 million from $30.6 million at year-end
2001.
Cash flows provided from operating activities of $78.3 million, together
with $104.0 million of proceeds from borrowings, primarily from the
Company's Competitive Advance and Revolving Facility Agreement ("Revolving
Credit Agreement"), were used primarily to purchase 4,000,000 shares of the
Company's common stock, to cover repayment of debt, capital expenditures,
and payment of dividends. The Company anticipates that cash provided from
operations in the future will be sufficient to pay its operating expenses,
satisfy debt-service obligations and
20
make dividend payments.
The change in the Company's accumulated other comprehensive income from
December 31, 2001, was primarily due to net foreign currency adjustments,
net of related deferred taxes, primarily related to the strengthening of
the Euro and Japanese Yen versus the U.S. Dollar.
The noncurrent portion of the Company's long-term debt amounted to $12.1
million at June 30, 2002, compared to $12.4 million at the end of 2001. The
Company's long-term debt, including the current portion, as a percentage of
total capitalization amounted to 28.0% at June 30, 2002. The Company is
guarantor of $14.5 million of long-term debt, in the form of commitments,
on behalf of its 50-percent owned joint venture company, Jordan Bromine
Company Limited. The Company's long-term debt, including the guarantee, as
a percent of total capitalization amounted to 29.4% at June 30, 2002.
The Company's Revolving Credit Agreement will mature on September 29, 2002.
Accordingly, the balance outstanding at June 30, 2002, is included in
current liabilities. The Company anticipates entering into a new three-year
credit agreement by September 1, 2002.
The Company's capital expenditures in the first six months of 2002 were
lower than the same period of 2001. For the year capital expenditures are
forecasted to be slightly lower than the 2001 level. Capital spending will
be financed primarily with cash flow from operations with additional cash
needed, if any, to be provided from debt. The amount and timing of any
additional borrowings will depend on the Company's specific cash
requirements.
The Company is subject to federal, state, local and foreign requirements
regulating the handling, manufacture and use of materials (some of which
may be classified as hazardous or toxic by one or more regulatory
agencies), the discharge of materials into the environment and the
protection of the environment. To the Company's knowledge, it currently is
complying, and expects to continue to comply, in all material respects with
existing environmental laws, regulations, statutes and ordinances. Such
compliance with federal, state, local and foreign environmental protection
laws is not expected to have in the future a material effect on earnings or
the competitive position of Albemarle.
Among other environmental requirements, the Company is subject to the
federal Superfund law, and similar state laws, under which the Company may
be designated as a potentially responsible party and may be liable for a
share of the costs associated with cleaning up various hazardous waste
sites.
Additional Information
Summary of Critical Accounting Policies:
Consolidation
The consolidated financial statements include the accounts and operations
of Albemarle Corporation and all of its majority-owned and controlled
subsidiaries. The Company applies the equity method of accounting for
investments between 20% and 50% owned over which the
21
Company has significant influence. All significant intercompany accounts
and transactions are eliminated in consolidation.
Estimates and Reclassifications
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of revenues, expenses, assets
and liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements. Actual results could differ from those
estimates.
Revenue Recognition
Sales revenue is recognized when (1) ownership and all rewards and risks of
loss have been transferred to the buyer, (2) the price is fixed and
determinable, and (3) collectibility is reasonably assured. Revenue from
services is recognized when costs of providing services are incurred.
Inventories
Inventories are stated at the lower of cost or market, with cost determined
on the last-in, first-out ("LIFO") basis for substantially all domestic
inventories except stores and supplies, and on either the weighted-average
or first-in, first-out cost basis for other inventories.
Property, Plant and Equipment
Accounts include costs of assets constructed or purchased, related delivery
and installation costs and interest incurred on significant capital
projects during their construction periods. Expenditures for renewals and
betterments also are capitalized, but expenditures for repairs and
maintenance are expensed as incurred. The cost and accumulated depreciation
applicable to assets retired or sold are removed from the respective
accounts, and gains or losses thereon are included in income. Depreciation
is computed primarily by the straight-line method based on the estimated
useful lives of the assets.
The Company evaluates historical and expected undiscounted operating cash
flows of the related business segments or fair value of property, plant and
equipment to determine the future recoverability of any property, plant and
equipment recorded. Recorded property, plant and equipment is re-evaluated
on the same basis at the end of each accounting period whenever any
significant permanent changes in business or circumstances have occurred
which might impair recovery.
The costs of brine leases and royalty interests are amortized using a
method approximating the units-of-production method.
Environmental Compliance and Remediation
Environmental compliance costs include the cost of purchasing and/or
constructing assets to prevent, limit and/or control pollution or to
monitor the environmental status at various locations. These costs are
capitalized and depreciated based on estimated useful lives.
Environmental compliance costs also include maintenance and operating costs
with respect to pollution prevention and control facilities and other
administrative costs. Such operating costs are expensed as incurred.
22
Environmental remediation costs of facilities used in current operations
are generally immaterial and are expensed as incurred.
The Company accrues for environmental remediation costs and
post-remediation costs on an undiscounted basis at facilities or off-plant
disposal sites that relate to existing conditions caused by past operations
in the accounting period in which responsibility is established and when
the related costs are estimable. In developing these cost estimates,
evaluation is given to currently available facts regarding each site, with
consideration given to existing technology, presently enacted laws and
regulations, prior experience in remediation of contaminated sites, the
financial capability of other potentially responsible parties and other
factors, subject to uncertainties inherent in the estimation process.
Additionally, these estimates are reviewed periodically, with adjustments
to the accruals recorded as necessary.
Pension Plans and Other Postretirement Benefits
Annual costs of pension plans are determined actuarially based on Financial
Accounting Standards Board ("FASB") Statement of Financial Accounting
Standards ("SFAS") No. 87, "Employers' Accounting for Pensions" ("SFAS No.
87"). The Company's policy is to fund U.S. pension plans at amounts not
less than the minimum requirements of the Employee Retirement Income
Security Act of 1974 and generally for obligations under its foreign plans
to deposit funds with trustees and/or under insurance policies. Annual
costs of other postretirement plans are accounted for based on SFAS No.
106, "Employers' Accounting for Postretirement Benefits Other than
Pensions." The policy of the Company is to fund post-retirement health
benefits for retirees on a pay-as-you-go basis. There are significant
assumptions used in determining amounts include the discount rate, expected
return on plan assets, rate of compensation increase and assumed health
care trend rate.
Income Taxes
The Company and its subsidiaries file consolidated U.S. Federal income tax
returns and individual foreign income tax returns.
Deferred income taxes result from temporary differences in the recognition
of income and expenses for financial and income tax reporting purposes,
using the liability or balance sheet method. Such temporary differences
result primarily from differences between the financial statement carrying
amounts and tax basis of assets and liabilities using enacted tax rates in
effect in the years in which the differences are expected to reverse. It is
the Company's policy to record deferred income taxes on any undistributed
earnings of foreign subsidiaries that are not deemed to be, or are not
intended to be, permanently reinvested in those subsidiaries.
Stock Based Compensation
The Company accounts for stock-based compensation using the intrinsic value
method prescribed in Accounting Principles Board No. 25, "Accounting for
Stock Issued to Employees" and related interpretations. Under the intrinsic
method, compensation cost for stock options is measured as the excess, if
any, of the quoted market price of the Company's stock at the date of grant
over the amount an employee must pay to acquire the stock.
Research and Development Expenses
The Company-sponsored research and development expenses related to present
and future products are expensed currently as incurred.
23
Outlook
Fine Chemicals
Overall for our Fine Chemicals business, we anticipate a stronger third
quarter than second quarter 2002 and believe 2002 should exceed last year's
operating profit. We believe there will be a good pick up in our
pharmaceutical business that will yield quarter-to-quarter growth. We
believe the higher production costs, which were incurred in a couple of
second quarter extended plant turnarounds, are behind us as we enter the
second half of the year. In our end markets, there could be significant
volatility going forward in our agrichemicals business where weather can be
a significant factor for our customers and their growing season. Therefore,
we anticipate that our agrichemicals business will be flat to down for the
third quarter versus the second quarter and for the year compared to 2001.
Polymer Chemicals
In our flame retardants business, even though we saw good volume growth in
the second quarter both sequentially and year-over-year, we are somewhat
concerned that this may have been caused by an inventory buildup in the
overall supply chain and are somewhat cautious about the outlook for the
balance of the year. The consumer electronics business sector, our major
end market, remains tenuous, especially in the printed wire board and epoxy
areas, where our customers are struggling to find signs of consistent
growth in consumer spending. The polyolefin end markets, that are the
primary drivers for our catalyst and additives business, appear to be
strengthening as their end markets and operating rates continue to improve.
In the second quarter, we announced price increases for a number of our
flame retardant products. Pricing had fallen to a level where action was
needed to improve operating margins to a level sufficient to sustain
business long term. We hope to implement the increases as soon as our
existing customer contracts allow. However, it will probably be the fourth
quarter before these begin to take hold.
While we have benefited in the first half of this year from lower raw
material costs versus the same period a year ago, we believe this will
begin to fade later this year as many of the price increases announced in
the industry by our suppliers are also implemented.
Incorporating the second quarter tax refund we received and based on an
expected tax rate in the second half of 2002 of 30%, we are now estimating
a 28% tax rate for the year.
We've had a strong start in our third quarter business. Our customers for
the most part believe that they are in a period of slow economic growth
that will continue through this year. While we are concerned about the slow
return of certain flame retardant markets and the current turmoil on Wall
Street, we are optimistic about our position and our ability to continue to
deliver quarterly earnings for the rest of this year that are an
improvement over those of 2001 and in line with the existing consensus
estimates for our corporation before any special items.
Additional information regarding the Company, its products, markets and
financial performance is provided at the Company's Internet web site,
www.Albemarle.com.
24
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no significant changes in our interest rate risk,
marketable security price risk or raw material price risk from the
information provided in our Form 10-K for the year ended December 31, 2001.
Part II - OTHER INFORMATION
ITEM 1. Legal Proceedings
The Company and its subsidiaries are involved from time to time in legal
proceedings of types regarded as common in the Company's businesses,
particularly administrative or judicial proceedings seeking remediation
under environmental laws, such as Superfund, and products liability
litigation.
While it is not possible to predict or determine the outcome of the
proceedings presently pending, in the Company's opinion they should not
result ultimately in liabilities likely to have a material adverse effect
upon the results of operations or financial condition of the Company and
its subsidiaries on a consolidated basis.
ITEM 5. Other Information
On May 31, 2002, the Company's Board of Directors announced changes in the
Company's senior management. Paul F. Rocheleau, was elected senior vice
President and Chief Financial Officer, succeeding Charles B. Walker. With
this appointment, Mr. Rocheleau resigned from his position on the Board of
Directors. Mr. Walker continues as Vice Chairman and now leads corporate
merger and acquisition activities.
On July 31, 2002, the Company announced that Mark C. Rohr has been elected
President and Chief Executive Officer, effective October 1, 2002. After
that date, Floyd D. Gottwald, Jr., will serve as Vice Chairman of the Board
and continue as Chairman of the Executive Committee.
At its July 31, 2002 meeting, Albemarle's Board of Directors increased its
regular quarterly dividend to 14 cents a share from 13 cents, payable
October 1, 2002, to shareholders of record September 13, 2002. The new
annualized dividend rate will be 56 cents per share.
25
ITEM 6. Exhibits and Reports on Form 8-K
(a) Exhibits
The following documents are filed as exhibits to this Form 10-Q
pursuant to Item 601 of Regulation S-K:
3(ii) By-laws of the registrant amended in June 2002 are filed
herewith
99. List of Albemarle Corporation Officers (filed herewith).
(b) No reports on Form 8-K have been filed during the quarter for
which this report is filed.
26
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ALBEMARLE CORPORATION
(Registrant)
Date: August 14, 2002
By: /s/ ROBERT G. KIRCHHOEFER
----------------------------
Robert G. Kirchhoefer
Treasurer and Chief Accounting Officer
(Principal Accounting Officer)
27
EXHBIT INDEX
Page
Numbers(s)
----------
3(ii) By-laws of the registrant amended in June 2002 are
filed herewith 29-51
99. List of Albemarle Corporation Officers (filed
herewith). 52
28